Black Rock Inc. Astrazeneca PLC Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Black Rock Inc. holds 7,019,423 shares of AZN stock, worth $469 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,019,423
Previous 838,000
737.64%
Holding current value
$469 Million
Previous $56.8 Million
864.25%
% of portfolio
0.01%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding AZN
# of Institutions
1,360Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.2 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.81 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.49 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.46 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.28 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $207B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...